|
A biotechnologist and entrepreneur with more than 12 years of experience in genomics, and 24 years of experience in life sciences research. Before co-founding Epitomics, Dr. Yu was Senior Vice-President of Research and Development at Mendel Biotechnology Inc. At Mendel Biotechnology, Dr. Yu established a robust functional genomics program, exceeded all six milestones for the Research Agreement with Monsanto and Savia, and managed over 60 Ph.D. scientists and research associates. Before joining Mendel Biotechnology, Dr. Yu was with Human Genome Sciences, Inc., a prominent genomics company, as one of the first Senior Scientists involved in the establishment of the high throughput gene discovery program. While at Human Genome Sciences, Dr. Yu led the technology development group and cancer group. He identified and characterized numerous genes for therapeutic protein and drug discovery. Dr. Yu was a Post-doctoral Fellow at the Harvard Medical School. He holds a Ph.D. degree in Molecular Biology from the University of California, Berkeley and a B.S. degree in Biochemistry from Fudan University, Shanghai, China. Dr. Yu is also the founder of the Chinese Biopharmaceutical Association headquartered in Washington DC. He is co-inventor and co-author of over 100 patents and scientific articles. | 